1.Evaluation progress of the application of staplers in thoracoscopic lung surgery
Shenghui LI ; Yijiu REN ; Hang SU ; Minglei YANG ; Guofang ZHAO ; Yongxiang SONG ; Xuefei HU ; Deping ZHAO ; Qi XUE ; Chang CHEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(05):709-713
Compared to traditional suturing, lung stapling using automatic staplers offers advantages such as smaller trauma, faster wound healing, ease of operation, and lower complication rates, making it widely used in clinical practice. However, there are significant differences in bronchial tissue thickness at different anatomical locations, and the market is flooded with various types of staplers. Currently, there is a lack of recommended stapling schemes for bronchial staplers at different anatomical locations. This article reviews the development and application of automatic staplers and summarizes some types of staplers that are currently used in clinical practice, with the aim of promoting the formation of individualized stapler selection protocols for minimally invasive thoracic surgery based on the Chinese population.
2.The Exploration of Characteristic Pricing Methods for Traditional Chinese Patent Medicines Based on Information Entropy Theory
Yijiu YANG ; Haili ZHANG ; Bin LIU ; Ning LIANG ; Huizhen LI ; Tian SONG ; Wenjie CAO ; Ziteng HU ; Yanping WANG ; Sheng HAN ; Nannan SHI
Chinese Health Economics 2025;44(2):13-17
Objective:To explore the method for selecting characteristic prices of Chinese patent medicines based on informa-tion entropy theory.It involves analyzing the connotative differences among various price indicators and utilizing information entropy metrics to validate the scientific rigor of characteristic price selection so as to optimize the pricing model for Chinese patent medi-cines and improve the accuracy of price evaluation.Methods:A correlation analysis and information entropy calculation are con-ducted on the median price of the smallest preparation unit,average daily cost,and average course cost of TCM.It compares the information diversity and uncertainty of different pricing indicators.Results:The average daily cost exhibits the highest information diversity and uncertainty among all the pricing indicators examined.Conclusion:It is recommended that the average daily cost be used as the dependent variable for characteristic prices in TCM pricing research.This choice plays an important role in optimizing TCM pricing models and enhancing the accuracy of price evaluation.
3.Research on the Construction of a Characteristic Price Variable Indicator System for Traditional Chinese Patent Medicines
Yijiu YANG ; Haili ZHANG ; Bin LIU ; Ning LIANG ; Huizhen LI ; Tian SONG ; Wenjie CAO ; Ziteng HU ; Houfang MA ; Yanping WANG ; Sheng HAN ; Nannan SHI
Chinese Health Economics 2025;44(2):18-23
Objective:To establish a scientific,systematic,and objective indicator system for the characteristic price variables of Traditional Chinese Patent Medicines(TCPM),providing a reference framework for the pricing mechanism of TCPM.Methods:The brainstorming method was initially used to screen related variable indicators.The Nominal Group Technique(NGT)and Delphi methods were applied to gather expert opinions,and SPSS 28.0 was employed for data statistical analysis.It led to the development of a TCPM characteristic price variable indicator system consisting of 6 dimensions,14 characteristic variables and 26 measurement indicators.Results:The authority coefficient of the experts exceeded 0.7,indicating the representativeness of the results.Expert opinions were generally concentrated.Based on the collected opinions and statistical analysis,the scope of selected TCPM characteristic price variables was preliminarily established.Conclusion:The TCPM characteristic price variable indicator system was initially developed.However,due to the complexity of the pricing mechanism and divergent expert opinions,further qualitative and quantitative research methods,along with a dynamic adjustment mechanism,are needed to verify and refine the system.
4.Design of Evidence-Based Decision-Making Pathway for the Selection of the National Essential Medicines List
Haili ZHANG ; Wenjie CAO ; Yijiu YANG ; Weili WANG ; Ning LIANG ; Ziteng HU ; Bin LIU ; Lijiao YAN ; Huizhen LI ; Zhaoyuan GONG ; Guozhen ZHAO ; Yanping WANG ; Nannan SHI
Chinese Health Economics 2025;44(1):15-19
The National Essential Medicines System could protect public health and ensure access to essential medications.Although the current selection methods for China's National Essential Medicines Lists(NEMLs)are becoming more scientific and standardized,there are still problems such as much emphasis on expert experience and the lack of transparency of decision-making basis.To address these issues,it proposes an evidence-based decision-making pathway for NEMLs selection guided by clinical value.This approach ensures a strong integration of evidence and decision-making,offering valuable insights for improving the adjustment procedures and selection criteria of the NEMLs in China.
5.The Exploration of Characteristic Pricing Methods for Traditional Chinese Patent Medicines Based on Information Entropy Theory
Yijiu YANG ; Haili ZHANG ; Bin LIU ; Ning LIANG ; Huizhen LI ; Tian SONG ; Wenjie CAO ; Ziteng HU ; Yanping WANG ; Sheng HAN ; Nannan SHI
Chinese Health Economics 2025;44(2):13-17
Objective:To explore the method for selecting characteristic prices of Chinese patent medicines based on informa-tion entropy theory.It involves analyzing the connotative differences among various price indicators and utilizing information entropy metrics to validate the scientific rigor of characteristic price selection so as to optimize the pricing model for Chinese patent medi-cines and improve the accuracy of price evaluation.Methods:A correlation analysis and information entropy calculation are con-ducted on the median price of the smallest preparation unit,average daily cost,and average course cost of TCM.It compares the information diversity and uncertainty of different pricing indicators.Results:The average daily cost exhibits the highest information diversity and uncertainty among all the pricing indicators examined.Conclusion:It is recommended that the average daily cost be used as the dependent variable for characteristic prices in TCM pricing research.This choice plays an important role in optimizing TCM pricing models and enhancing the accuracy of price evaluation.
6.Research on the Construction of a Characteristic Price Variable Indicator System for Traditional Chinese Patent Medicines
Yijiu YANG ; Haili ZHANG ; Bin LIU ; Ning LIANG ; Huizhen LI ; Tian SONG ; Wenjie CAO ; Ziteng HU ; Houfang MA ; Yanping WANG ; Sheng HAN ; Nannan SHI
Chinese Health Economics 2025;44(2):18-23
Objective:To establish a scientific,systematic,and objective indicator system for the characteristic price variables of Traditional Chinese Patent Medicines(TCPM),providing a reference framework for the pricing mechanism of TCPM.Methods:The brainstorming method was initially used to screen related variable indicators.The Nominal Group Technique(NGT)and Delphi methods were applied to gather expert opinions,and SPSS 28.0 was employed for data statistical analysis.It led to the development of a TCPM characteristic price variable indicator system consisting of 6 dimensions,14 characteristic variables and 26 measurement indicators.Results:The authority coefficient of the experts exceeded 0.7,indicating the representativeness of the results.Expert opinions were generally concentrated.Based on the collected opinions and statistical analysis,the scope of selected TCPM characteristic price variables was preliminarily established.Conclusion:The TCPM characteristic price variable indicator system was initially developed.However,due to the complexity of the pricing mechanism and divergent expert opinions,further qualitative and quantitative research methods,along with a dynamic adjustment mechanism,are needed to verify and refine the system.
7.Design of Evidence-Based Decision-Making Pathway for the Selection of the National Essential Medicines List
Haili ZHANG ; Wenjie CAO ; Yijiu YANG ; Weili WANG ; Ning LIANG ; Ziteng HU ; Bin LIU ; Lijiao YAN ; Huizhen LI ; Zhaoyuan GONG ; Guozhen ZHAO ; Yanping WANG ; Nannan SHI
Chinese Health Economics 2025;44(1):15-19
The National Essential Medicines System could protect public health and ensure access to essential medications.Although the current selection methods for China's National Essential Medicines Lists(NEMLs)are becoming more scientific and standardized,there are still problems such as much emphasis on expert experience and the lack of transparency of decision-making basis.To address these issues,it proposes an evidence-based decision-making pathway for NEMLs selection guided by clinical value.This approach ensures a strong integration of evidence and decision-making,offering valuable insights for improving the adjustment procedures and selection criteria of the NEMLs in China.
8.Analysis of Influencing factors of incision complications after craniocerebrovascular reconstruction
Hongchao YANG ; Tong ZHOU ; Chuanqing LI ; Yijiu YAN ; Manyi XIE
Chongqing Medicine 2024;53(10):1543-1547,1552
Objective To explore the risk factors of incision complications after cerebral revasculariza-tion.Methods The patients who underwent vascular reconstruction for craniocerebral vascular diseases in the Affiliated Hospital of Xuzhou Medical University who underwent revascularization for cerebrovascular disea-ses from January 2018 to December 2022 were retrospectively included,and the patients were divided into the incision complications group and the no incision complications group.Among them,this study documented the delayed complications following incision healing after cerebral revascularization.The baseline clinical data of patients'demographics and incisional complications after cerebral revascularization were recorded,and possi-ble influencing factors were included in a binary logistic regression analysis to analyze the influencing factors that may contribute to the occurrence of incisional complications after cerebral revascularization.Results A total of 117 patients who underwent cerebral revascularization were included,including 25 cases(21.4%)in the group with incision complications,including 7 cases(28.0%)of fat liquefaction,4 cases(16.0%)of inci-sion dehiscence,7 cases(28.0%)of incision infection,and 7 cases(28.0%)of necrosis,while 92 cases(78.6%)in the group without incisional complications.Univariate analysis showed that there was no statisti-cally significant difference in gender,age,hypertension,hyperlipidemia,smoking,drinking,disease type,and vascular reconstruction type between the patients with incision complications after cerebral revascularization and those without incision complications(P>0.05).The proportion of patients with diabetes mellitus and the frontal branches of superficial temporal artery not preserved in the incision complications group was higher than in the no incision complications group.BMI,scalp thickness,and operation time in the group with incision complications were higher than those in the no incision complications group,and the difference was statistical-ly significant(P<0.05).Multifactorial analysis showed that scalp thickness(OR=1.484,95%CI:1.024-2.149,P=0.037),BMI(OR=1.323,95%CI:1.042-1.680,P=0.021),and the absence of the frontal branch of the superficial temporal artery(OR=3.582,95%CI:1.146-11.190,P=0.028),were the main risk factors for incisional complications(P<0.05).Conclusion BMI,scalp thickness,and failure to preserve the frontal branch of the superficial temporal artery are independent risk factors for scalp incision complica-tions after cerebral revascularization.
9.Quality Evaluation of the Randomized Controlled Trials of Chinese Medicine Injection for Acute Cerebral Infarction in Last Five Years Based on ROB and CONSORT-CHM Formulas 2017
Ziteng HU ; Qianzi CHE ; Ning LIANG ; Yujing ZHANG ; Yaxin CHEN ; Fuqiang ZHANG ; Weili WANG ; Haili ZHANG ; Wenjie CAO ; Yijiu YANG ; Tian SONG ; Dingyi WANG ; Xingyu ZONG ; Cuicui CHENG ; Yin JIANG ; Yanping WANG ; Nannan SHI
Chinese Journal of Information on Traditional Chinese Medicine 2024;31(7):32-37
Objective To evaluate the risk of bias and reporting quality in randomized controlled trials(RCTs)of the Chinese medicine injection for acute cerebral infarction in the last five years.Methods RCTs literature on Chinese medicine injection in the treatment of acute cerebral infarction was systematically searched in CNKI,Wanfang Data,VIP,China Biology Medicine Database(CBM),PubMed,Embase and Cochrane Library from April 20,2018 to April 20,2023.The risk of bias and reporting quality of included RCTs were evaluated using the Cochrane Risk of Bias Tool(ROB 1.0)and CONSORT-CHM Formulas 2017,respectively.Results A total of 4 301 articles were retrieved,and 408 RCTs were included according to inclusion and exclusion criteria.The ROB evaluation results showed that the the majority of studies were rated as having an unclear risk of bias due to the lack of reporting on allocation concealment,blind method,trial registration information,and funding sources.The evaluation results of CONSORT-CHM Formulas 2017 showed that the number of reported papers of 17 items was greater than or equal to 50%,and the number of reported papers of 25 items was less than 10%,and most of the RCTs did not show the characteristics of TCM syndrome differentiation and treatment.Conclusion The quality of Chinese medicine injection in the treatment of acute cerebral infarction RCTs is generally low.It is recommended that researchers refer to the methodology design of RCTs and international reporting standards,improve the trial design,standardize the trial report,and highlight the characteristics of TCM syndrome differentiation and treatment.
10.Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine:weighting of evaluation indicators
Haili ZHANG ; Bin LIU ; Weili WANG ; Wenjie CAO ; Yijiu YANG ; Ziteng HU ; Yaxin CHEN ; Ning LIANG ; Huizhen LI ; Qianzi CHE ; Xingyu ZONG ; Zhao CHEN ; Yanping WANG ; Nannan SHI
China Pharmacy 2024;35(7):773-777
OBJECTIVE To provide a detailed report and interpretation of the method and results for determining the weights of the technical indicators from the “multi-dimensional and multi-criteria comprehensive evaluation index system (first edition)” stated in Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine. METHODS Normalization calculations were performed on the comprehensive weight values calculated by the analytic hierarchy process and expert weighting method to obtain the objective weights of the indicators. RESULTS The weight results of the six primary dimensions in the current comprehensive evaluation indicator system of Chinese patent medicine showed effectiveness dimension> safety dimension>standard dimension>application dimension>scientific dimension>economic dimension, with weight values of 0.281 0, 0.268 5, 0.195 8, 0.107 3, 0.096 1 and 0.051 3 respectively, consistent with the results of most researches currently. CONCLUSIONS The process of weight determination in this indicator system is scientifically reasonable, with clear methods and clear interpretations, and is worthy of further optimization and widespread application.

Result Analysis
Print
Save
E-mail